Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1977 1
1978 1
1979 1
1980 2
1981 2
1983 4
1984 2
1985 3
1986 1
1987 1
1988 1
1989 2
1990 2
1991 2
1992 2
1993 1
1995 3
1996 4
1997 1
1998 3
1999 5
2000 8
2001 5
2002 9
2003 11
2004 8
2005 7
2006 6
2007 3
2008 5
2009 2
2010 3
2011 3
2012 11
2013 9
2014 12
2015 8
2016 5
2017 5
2018 8
2019 7
2020 5
2021 3
2022 7
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

185 results

Results by year

Filters applied: . Clear all
Page 1
Cutaneous reactive B-cell lymphoid proliferations.
Khalil S, Donthi D, Gru AA. Khalil S, et al. J Cutan Pathol. 2022 Oct;49(10):898-916. doi: 10.1111/cup.14264. Epub 2022 Aug 4. J Cutan Pathol. 2022. PMID: 35656820 Review.
Cutaneous lymphoid hyperplasia (CLH), also known as cutaneous pseudolymphoma, is a spectrum of benign conditions characterized by reactive B- and T-cell cutaneous lymphocytic infiltrates. B-cell lymphoid proliferations are a heterogenous group of non-neoplastic cutaneous d …
Cutaneous lymphoid hyperplasia (CLH), also known as cutaneous pseudolymphoma, is a spectrum of benign conditions characterized by rea …
Pseudolymphomatous Atypical Fibroxanthoma.
Garcia Castro R, Viñolas-Cuadros A, Moyano-Bueno D, Conde-Ferreiros A, Cardeñoso E, Santos-Briz A. Garcia Castro R, et al. Am J Dermatopathol. 2020 Dec;42(12):972-976. doi: 10.1097/DAD.0000000000001761. Am J Dermatopathol. 2020. PMID: 32769551
Cutaneous lymphoid hyperplasias.
Gilliam AC, Wood GS. Gilliam AC, et al. Semin Cutan Med Surg. 2000 Jun;19(2):133-41. doi: 10.1016/s1085-5629(00)80011-5. Semin Cutan Med Surg. 2000. PMID: 10892716 Review.
Benign hyperplastic lymphoid infiltrates of the skin (pseudolymphoma, older term) simulate lymphoma clinically and histologically. ...Molecular biologic analysis has shown that a significant proportion of cases harbor occult B- or T-cell clones (clonal CLH). Progression to …
Benign hyperplastic lymphoid infiltrates of the skin (pseudolymphoma, older term) simulate lymphoma clinically and histologically. .. …
Cutaneous targets in drug-induced reactions.
Filotico R, Mastrandrea V. Filotico R, et al. G Ital Dermatol Venereol. 2014 Apr;149(2):227-35. G Ital Dermatol Venereol. 2014. PMID: 24819644 Review.
Clinical, developmental and medical history is important to define an ADR but sometimes you need to make histological examination to get additional diagnostic indications. However, the histological findings observed during the ADRs are hardly or not easily distinguishable …
Clinical, developmental and medical history is important to define an ADR but sometimes you need to make histological examination to get add …
Iron induces B cell pyroptosis through Tom20-Bax-caspase-gasdermin E signaling to promote inflammation post-spinal cord injury.
Wu C, Wang L, Chen S, Shi L, Liu M, Tu P, Sun J, Zhao R, Zhang Y, Wang J, Pan Y, Ma Y, Guo Y. Wu C, et al. J Neuroinflammation. 2023 Jul 22;20(1):171. doi: 10.1186/s12974-023-02848-0. J Neuroinflammation. 2023. PMID: 37480037 Free PMC article.
METHODS: A mouse model of SCI was established, and HE staining and Nissl staining were performed to observe the pathological changes. The size and morphology of the spleen were examined, and the effects of SCI on spleen function and B cell levels were detected by flow cyto …
METHODS: A mouse model of SCI was established, and HE staining and Nissl staining were performed to observe the pathological changes. …
Treatment of Cutaneous Pseudolymphoma: A Systematic Review.
Miguel D, Peckruhn M, Elsner P. Miguel D, et al. Acta Derm Venereol. 2018 Mar 13;98(3):310-317. doi: 10.2340/00015555-2841. Acta Derm Venereol. 2018. PMID: 29136262 Free article. Review.
Cutaneous pseudolymphoma (CPL) is a reactive polyclonal T- or B-cell lymphoproliferative process. ...The review was based on articles from the PubMed database, using the query "skin pseudolymphoma treatment", English and German, about "human" subjects, and published …
Cutaneous pseudolymphoma (CPL) is a reactive polyclonal T- or B-cell lymphoproliferative process. ...The review was based on articles …
Review of the European Society for Photodynamic Therapy (Euro-PDT) Annual Congress 2022.
Morton CA, Szeimies RM, Braathen LR. Morton CA, et al. Eur J Dermatol. 2023 Oct 1;33(5):467-473. doi: 10.1684/ejd.2023.4562. Eur J Dermatol. 2023. PMID: 38297922 Review.
Sequential treatment of AK and photoaging with daylight-PDT and injectable NASHA gel indicates that these two therapeutic approaches offer complementary effects. Potential biomarkers may help predict responsiveness of patients with field cancerization and AK receiving dayl …
Sequential treatment of AK and photoaging with daylight-PDT and injectable NASHA gel indicates that these two therapeutic approaches offer c …
Drug-induced cutaneous pseudolymphoma: A systematic review of the literature.
Etesami I, Kalantari Y, Tavakolpour S, Mahmoudi H, Daneshpazhooh M. Etesami I, et al. Australas J Dermatol. 2023 Feb;64(1):41-49. doi: 10.1111/ajd.13951. Epub 2022 Nov 4. Australas J Dermatol. 2023. PMID: 36331821 Review.
Drug-induced cutaneous pseudolymphoma (CPL) is a common form of pseudolymphoma and there are numerous drugs associated with it. ...The shortest median time interval between taking the drug and the onset of the disease was observed among patients taking antide …
Drug-induced cutaneous pseudolymphoma (CPL) is a common form of pseudolymphoma and there are numerous drugs associated with it …
Vaccination-induced cutaneous pseudolymphoma.
Maubec E, Pinquier L, Viguier M, Caux F, Amsler E, Aractingi S, Chafi H, Janin A, Cayuela JM, Dubertret L, Authier FJ, Bachelez H. Maubec E, et al. J Am Acad Dermatol. 2005 Apr;52(4):623-9. doi: 10.1016/j.jaad.2004.12.021. J Am Acad Dermatol. 2005. PMID: 15793512
We report herein a series of 9 patients presenting with cutaneous and subcutaneous pseudolymphoma. OBSERVATIONS: Nine patients presenting with late-onset, chronic skin lesions occurring at the site of antihepatitis B (8 cases) and antihepatitis A (one case) vaccinat …
We report herein a series of 9 patients presenting with cutaneous and subcutaneous pseudolymphoma. OBSERVATIONS: Nine patients …
Hepatic pseudolymphoma: a clinicopathological study of five cases and review of the literature.
Zen Y, Fujii T, Nakanuma Y. Zen Y, et al. Mod Pathol. 2010 Feb;23(2):244-50. doi: 10.1038/modpathol.2009.165. Epub 2009 Nov 13. Mod Pathol. 2010. PMID: 19915525 Free article. Review.
Hepatic pseudolymphoma is a rare and controversial condition, the clinicopathological characteristics of which have not been well documented. ...Interestingly, their nodules spontaneously diminished in size without any treatment. Malignant transformation was not observe …
Hepatic pseudolymphoma is a rare and controversial condition, the clinicopathological characteristics of which have not been well doc …
185 results